摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4R)-dihydro-2,2-dimethyl-4-amino-3-hydroxy-1-benzopyran6-carbonitrile | 205312-11-4

中文名称
——
中文别名
——
英文名称
(3R,4R)-dihydro-2,2-dimethyl-4-amino-3-hydroxy-1-benzopyran6-carbonitrile
英文别名
(3R,4R)-4-amino-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carbonitrile
(3R,4R)-dihydro-2,2-dimethyl-4-amino-3-hydroxy-1-benzopyran6-carbonitrile化学式
CAS
205312-11-4
化学式
C12H14N2O2
mdl
——
分子量
218.255
InChiKey
APHWBGUCQBONMO-GHMZBOCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    79.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3R,4R)-dihydro-2,2-dimethyl-4-amino-3-hydroxy-1-benzopyran6-carbonitrilepotassium carbonate苯硫酚三乙胺 、 sodium iodide 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 72.5h, 生成 (4aR,10bR)-5,5-dimethyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano[3,4-b][1,4]oxazine-9-carbonitrile
    参考文献:
    名称:
    N -Acyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano-[3,4- b ][1,4]oxazine-9-carbonitriles as bladder-selective potassium channel openers
    摘要:
    Optically active N-acyl-5,5-dimethyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano[3,4-b][1,4]oxazine-9-carbonitriles 2-22 were synthesized as rigid analogues of cromakalim. The (4aR,10br)-N-benzoyl derivative (-)-11 was identified as a bladder-selective KCO (IC50, (bladder) = 82 muM, IC50, (portal vein) = 34.5 muM). Among the analogues of 11 with substitution on the benzoyl moiety, the 3-methyl analogue (-)-14 showed highly potent and selective activity at portal vein (IC50, (bladder) = 279 muM, IC50, (portal vein) = 0.54 muM). The 4-bromo analogue (-)-19 (IC50, (bladder) = 2.0 muM, IC50, (portal vein) = 8.1 muM) and the 4-hydroxy analogue (-)-21 (IC50, (bladder) = 3.8 muM, IC50, portal vein = 75 muM) showed enhanced activity at the bladder, while maintaining unprecedented bladder selectivity in vitro. The N-benzenesulfonyl analogue (-)-22, a bioisoster of (-)-11, showed similar activity at the bladder with enhanced selectivity (IC50, bladder = 116 muM, IC50, portal vein = 120 muM) (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00260-1
  • 作为产物:
    参考文献:
    名称:
    N -Acyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano-[3,4- b ][1,4]oxazine-9-carbonitriles as bladder-selective potassium channel openers
    摘要:
    Optically active N-acyl-5,5-dimethyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano[3,4-b][1,4]oxazine-9-carbonitriles 2-22 were synthesized as rigid analogues of cromakalim. The (4aR,10br)-N-benzoyl derivative (-)-11 was identified as a bladder-selective KCO (IC50, (bladder) = 82 muM, IC50, (portal vein) = 34.5 muM). Among the analogues of 11 with substitution on the benzoyl moiety, the 3-methyl analogue (-)-14 showed highly potent and selective activity at portal vein (IC50, (bladder) = 279 muM, IC50, (portal vein) = 0.54 muM). The 4-bromo analogue (-)-19 (IC50, (bladder) = 2.0 muM, IC50, (portal vein) = 8.1 muM) and the 4-hydroxy analogue (-)-21 (IC50, (bladder) = 3.8 muM, IC50, portal vein = 75 muM) showed enhanced activity at the bladder, while maintaining unprecedented bladder selectivity in vitro. The N-benzenesulfonyl analogue (-)-22, a bioisoster of (-)-11, showed similar activity at the bladder with enhanced selectivity (IC50, bladder = 116 muM, IC50, portal vein = 120 muM) (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00260-1
点击查看最新优质反应信息

文献信息

  • Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
    申请人:E.R. SQUIBB & SONS, INC.
    公开号:EP0462761A2
    公开(公告)日:1991-12-27
    A new method for the treatment of ischemic conditions and arrhythmia is disclosed. The method uses compounds of the formula wherein A can be -CH₂-, -O-, -NR₉-, -S-, -SO-, -SO₂-; X can be oxygen or sulfur; Y can be -NR₈, -O-, -S-, -CH₂- and the R groups are as defined herein. Novel compounds within the definition of formula I are also disclosed.
    本研究公开了一种治疗缺血性疾病和心律失常的新方法。该方法使用式 其中 A 可以是-CH₂-、-O-、-NR₉-、-S-、-SO-、-SO₂-;X 可以是氧或硫;Y 可以是-NR₈、-O-、-S-、-CH₂-,R 基团如本文所定义。还公开了符合式 I 定义的新型化合物。
  • Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 2. Structure-Activity Studies on Benzopyranylcyanoguanidines; Modification of the Benzopyran Ring
    作者:Karnail S. Atwal、Gary J. Grover、Francis N. Ferrara、Syed Z. Ahmed、Paul G. Sleph、Steven Dzwonczyk、Diane E. Normandin
    DOI:10.1021/jm00011a016
    日期:1995.5
    The ATP-sensitive potassium channel (K-ATP) openers are of considerable interest as myocardial protecting agents. However, there exists a narrow window of safety for the use of first-generation compounds as antiischemic agents due to their powerful peripheral vasodilating effects, which can result in underperfusion of the area already at risk. We have recently disclosed the discovery of benzopyranylcyanoguanidine type K-ATP openers (BMS-180448) which are more selective for the ischemic myocardium compared to the first-generation compounds. This publication deals with structure-activity relationships for the antiischemic activity of the lead compound 8. The presence of an electron-withdrawing group at C6, an sp(3) center at C4, and a gem-dimethyl group at C2 appears to be essential for antiischemic activity. Cyanoguanidine can be replaced with a urea moiety. The results reported here support the hypothesis that distinct structure-activity relationships exist for antiischemic and vaso:relaxant activities of compounds related to 8 and cromakalim. The trifluoromethyl analog 10 is 550-fold more selective in vitro for the ischemic myocardium compared to the first-generation agent cromakalim. The reasons for the selectivity of these compounds for the ischemic myocardium are not clear at the present time. They may be related to the existence of receptor subtypes in smooth muscle and the myocardium.
  • Synthesis of 2,3,4a,11b-tetrahydro-oxazino[2,3-c]benzopyran-9-carbonitriles as ATP-sensitive potassium channel openers
    作者:Chen-Yu Cheng、Hsin-I Chiu、Ming-Jyh Chang、Yen-Chung Lin、Ming-Cheng Tsai、Hon-Cheng Yu
    DOI:10.1016/s0960-894x(98)00046-8
    日期:1998.3
    A series of optically active tetrahydro-oxazino[2,3-c]benzopyran derivatives have been synthesized and evaluated for potassium channel opening activity. (4aR,11bR)-1-Benzoyl-5,5-dimethyl-2,3,4a,11b-tetrahydro-oxazino[2,3-c]benzopyran-9-carbonitrile ((-)-11e) was identified as a bladder-selective potassium channel opener (IC50,bladder = 8.15 mu M, IC50,portal vein = 34.5 mu M). (C) 1998 Elsevier Science Ltd. All rights reserved.
  • Chromanol derivatives
    申请人:BEECHAM GROUP PLC
    公开号:EP0139992B1
    公开(公告)日:1988-12-28
  • US4687779A
    申请人:——
    公开号:US4687779A
    公开(公告)日:1987-08-18
查看更多